What is the current 4Front Ventures Corp share price?

The current share price of 4Front Ventures Corp is $ 0.005

How many 4Front Ventures Corp shares are in issue?

4Front Ventures Corp has 916,382,522 shares in issue

What is the market cap of 4Front Ventures Corp?

The market capitalisation of 4Front Ventures Corp is CAD 4.58M

What is the 1 year trading range for 4Front Ventures Corp share price?

4Front Ventures Corp has traded in the range of $ 0.00 to $ 0.00 during the past year

What is the PE ratio of 4Front Ventures Corp?

The price to earnings ratio of 4Front Ventures Corp is -0

What is the cash to sales ratio of 4Front Ventures Corp?

The cash to sales ratio of 4Front Ventures Corp is 0

What is the registered address of 4Front Ventures Corp?

The registered address for 4Front Ventures Corp is 7010 East Chauncey Lane, Phoenix, Arizona, 85054

What is the 4Front Ventures Corp website address?

The website address for 4Front Ventures Corp is 4frontventures.com

Which industry sector does 4Front Ventures Corp operate in?

4Front Ventures Corp operates in the Pharmaceuticals sector

4Front Ventures【FFNT】銘柄情報

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

期間 †

前日比

前日比 %

始値

高値

安値

平均出来高

VWAP

156

260

4Front Ventures Reports First Quarter 2021 Financial Results and Provides Business Update

Canada NewsWire
PHOENIX, Ariz., May 24, 2021

Q1 2021 Systemwide Pro Forma Revenue of $31.4 million, an increase of 26% over Q4 2020

Q1 2021 Adjusted EBITDA of $5.9 million, representing an Adjusted EBITDA Margin of 19%

Reiterated FY2021 guidance for Systemwide Pro Forma Revenue of $170-180 million and Adjusted EBITDA of $40-50 million

The Company's existing licensed projects at maturity represent a long-term revenue and EBITDA opportunity upwards of $650 million and $250 million, respectively

Conference call to be held today, May 24, 2021 at 5:00 p.m. ET

PHOENIX, Ariz., May 24, 2021 /CNW/ - 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) ("4Front" or the "Company"), a vertically integrated, multi-state cannabis operator and retailer, today announced its financial results for the first quarter ended March 31, 2021. All financial information is presented in U.S. dollars unless otherwise indicated.

First Quarter 2021 ("Q1 2021") Financial Results Highlights

Systemwide Pro Forma Revenue was $31.4 million
GAAP-reported revenue was $23.0 million
Adjusted EBITDA was $5.9 million

Operational Highlights

Strong performance in sales and product adoption across retail locations, exceeding all internal projections; positive momentum continues in Q2

California

Company's state-of-the-art 170,000 square foot production facility in Commerce, California is on track for planned Q2 2021 opening
Certificate of Occupancy anticipated in the next ten days
Signed distribution agreement with Nabis, a leading wholesale cannabis distributor to more than 750 stores in California

Massachusetts

The Company received its Certificate of Occupancy and approval to operate from the Town of Brookline for its third adult-use dispensary in Massachusetts

Grand opening in June 2021 pending final approval from the Cannabis Control Commission

Illinois

Secured land and funding for new cultivation and production facility in Illinois; groundbreaking scheduled to occur in Q3 2021

Management Commentary

"Our strategy of replicating low-cost production methods in new markets began to take shape and grow at scale in Massachusetts, Illinois and California in our first quarter, extending the momentum we created in 2020," said Leo Gontmakher, Chief Executive Officer of 4Front. "Utilizing the cultivation and production techniques developed for our facilities in Washington, we have increased the yields and quality of our products produced in both Illinois and Massachusetts, which has enabled us to supply our adult use dispensaries to meet the ever-increasing demand in those markets. As production increases, we plan to begin selling excess product into the wholesale market as well."

Mr. Gontmakher added, "Continued positive momentum following the initiation of adult use sales in late 2020 in both Georgetown and Worcester, Massachusetts, along with an exceptionally strong launch of our Calumet City, Illinois dispensary in December, contributed to our robust sequential Q1 sales increases and exceeded all internal expectations. Looking ahead, with the completion and opening of our manufacturing facility in Commerce, California just a few weeks out, we expect to be in the market imminently with our suite of high-quality, branded products. As the largest legal cannabis market in the world, California offers a unique opportunity to build efficient operations and create incredible products that are replicable across our nationwide footprint."

Mr. Gontmakher concluded, "With revenue-generating operations now in California, Illinois, Massachusetts, Michigan, and Washington, we are poised to further scale the business according to our expansion strategy for 2021. We continue to track towards our stated financial guidance for the year, anticipating $170-$180 million in Pro Forma Systemwide Revenue and $40-$50 million in Adjusted EBITDA."

Business Updates and Developments

Systemwide pro forma revenue increased 26% to $31.4 million in Q1 2021, compared to $25.0 million in Q4 2020. Retail sales and product adoption exceeded internal expectations. This increase was primarily due to higher sales from the two Massachusetts dispensaries following the start of adult use sales in the second half of 2020, and a very strong launch from the Calumet City dispensary that opened in December 2020.

Q1 2021 Adjusted EBITDA was $5.9 million, steady with Q4 2020 representing an adjusted EBITDA margin of 19%. EBITDA margin in the quarter was negatively impacted by the ramp up of the Company's expanded grow facility in Illinois. While the tripling of the Company's Illinois cultivation facility's flowering canopy was completed on time and under budget, the first harvest from the expanded facility was not completed until April, leading to a one-time, higher than expected average cost per gram for manufactured products in Q1 2021. Through the first month of Q2, 4Front has more than tripled its Illinois harvest output and expects a meaningful rebound in margins in Q2.

The Company's fully-funded, state-of-the-art 170,000 square foot manufacturing facility in Commerce, California is nearing completion and remains on track to be ready to serve the California cannabis market beginning in Q2 2021. The Company's first suite of products will include edibles, tinctures, capsules and infused pre-rolls, including Marmas™, Pebbles™, Chewees™, Hi-Burst™, Verdure™ and Terp Stix™. The Company has signed a distribution agreement with Nabis, a leading distributor of cannabis products. Nabis distributes brands to more than 750 dispensaries in California, covering 99% of licensed retailers in the state.

Construction of the Company's third Massachusetts Mission Dispensary in Brookline is complete. The Company also announced that it has cleared all municipal processes with the City of Brookline including receiving its Certificate of Occupancy. Pending final approval from the Cannabis Control Commission, the grand opening is slated for June 2021.

In Illinois, the recently announced development of our new cultivation and production facility continues as scheduled with construction beginning in Q3 2021. The first phase, a 258,000 square foot building with 65,000 square feet of flowering canopy and approximately 70,000 square feet of manufacturing space is on track to break ground in Q3 2021.

Conference Call

The Company will host a conference call and webcast on Monday, May 24, 2021 at 5:00 p.m. ET to review its operational and financial results and provide an update on current business trends.

To join the call, dial 1-877-407-0792 toll free from the United States or Canada or 1-201-689-8263 if dialing from outside those countries. The webcast can be accessed at this link.

The call will be available for replay until Monday, May 31, 2021. To access the telephone replay, dial 1-844-512-2921 toll free from the United States and Canada, or 1-412-317-6671 if dialing from outside those countries, and use this replay pin number: 13719936.

About 4Front Ventures Corp.

4Front (CSE: FFNT) (OTCQX: FFNTF) is a national multi-state cannabis operator and retailer, with a market advantage in mass-produced, low-cost quality branded cannabis products. 4Front manufactures and distributes a portfolio of over 21 cannabis brands including Marmas, Crystal Clear, Funky Monkey, Pebbles, and the Pure Ratios wellness collection, distributed through retail outlets and their chain of strategically positioned Mission branded dispensaries. Headquartered in Phoenix, Arizona, 4Front has operations in Illinois, Massachusetts, California, Michigan, and Washington state. From plant genetics to the cannabis retail experience, 4Front's team applies expertise across the entire cannabis value chain. For more information, visit www.4frontventures.com.

Outstanding Shares
566,186,697
03/31/2021

Financial Statements

4FRONT VENTURES CORP.
Formerly 4Front Holdings, LLC
Consolidated Balance Sheets
As of March 31, 2021 and December 31, 2020

March 31,
2021

December 31,
2020

ASSETS

Current assets:

Cash

$

17,806

$

18,932

Accounts receivable

390

437

Other receivables

195

1,341

Current portion of lease receivables

3,495

3,450

Inventory

18,971

18,037

Current portion of notes receivable

292

264

Prepaid expenses

3,105

2,275

Total current assets

44,254

44,736

Property and equipment, net

39,542

33,618

Notes receivable and accrued interest

—

91

Lease receivables

7,486

7,595

Intangible assets, net

28,207

28,790

Goodwill

23,155

23,155

Right-of-use assets

61,593

62,466

Deposits

4,685

4,305

TOTAL ASSETS

$

208,922

$

204,756

LIABILITIES AND SHAREHOLDERS' EQUITY

LIABILITIES

Current liabilities:

Accounts payable

$

6,576

$

4,722

Accrued expenses and other current liabilities

8,213

6,427

Taxes payable

13,308

11,502

Derivative liability

8,339

5,807

Current portion of convertible notes

2,160

1,652

Current portion of lease liability

1,795

1,909

Current portion of contingent consideration payable

2,393

Current portion of notes payable and accrued interest

3,852

3,372

Total current liabilities

44,243

37,784

Convertible notes

11,466

14,722

Notes payable and accrued interest from related party

45,704

45,362

Long term notes payable

1,838

1,907

Long term accounts payable

1,600

1,600

Contingent consideration payable

3,212

3,103

Deferred tax liability

7,162

6,530

Lease liability

51,334

51,545

TOTAL LIABILITIES

166,559

162,553

SHAREHOLDERS' EQUITY (DEFICIENCY)

Equity attributable to 4Front Ventures Corp.

259,431

250,583

Additional paid-in capital

44,512

42,116

Deficit

(261,637)

(250,548)

Total 4Front Ventures Corp. shareholders' equity

42,306

42,151

Non-controlling interest

57

52

TOTAL SHAREHOLDERS' EQUITY

42,363

42,203

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

$

208,922

$

204,756

4FRONT VENTURES CORP.
Formerly 4Front Holdings, LLC
Consolidated Statements of Operations and Comprehensive Loss
For the Three Months Ended March 31, 2021 and March 31, 2020

Three Months Ended March 31,

2021

2020

REVENUE

Revenue from sale of goods

$

20,080

$

9,755

Real estate income

2,890

2,897

Total revenues

22,970

12,652

Cost of goods sold, sale of grown and manufactured products

(5,335)

(2,815)

Cost of goods sold, sale of purchased products

(3,790)

(1,834)

Gross profit

13,845

8,003

OPERATING EXPENSES

Selling and marketing expenses

5,157

6,816

General and administrative expenses

5,165

5,108

Equity based compensation

2,396

1,227

Depreciation and amortization

774

913

Accretion

—

(37)

Total operating expenses

13,492

14,027

Income (Loss) from operations

353

(6,024)

Other income (expense)

Interest income

3

56

Interest expense

(2,461)

(2,136)

Amortization of loan discount upon conversion of debt to equity

(2,915)

—

Change in fair value of derivative liability

(2,532)

—

Loss on lease termination

(879)

—

Total other income (expense)

(8,784)

(2,080)

Net loss before income taxes

(8,431)

(8,104)

Income tax expense

(2,653)

(550)

Net loss from continuing operations, net of taxes

(11,084)

(8,654)

Net income from discontinued operations, net of taxes

—

872

Net loss

(11,084)

(7,782)

Net loss attributable to non-controlling interest

5

12

Net loss attributable to shareholders

$

(11,089)

$

(7,794)

Basic and diluted loss per share

$

(0.02)

$

(0.01)

Weighted average number of shares outstanding, basic and diluted

558,997,571

531,521,620

Note Regarding Non-GAAP Measures, Reconciliation, and Discussion

In this press release, 4Front refers to certain non-GAAP financial measures such as Systemwide Pro Forma Revenue and Adjusted EBITDA. These measures do not have any standardized meaning prescribed by GAAP and may not be comparable to similar measures presented by other issuers. 4Front defines Systemwide Pro Forma Revenue as total revenue plus revenue from entities with which the Company has a management contract, or effectively similar relationship (net of any management fee or effectively similar revenue) but does not consolidate the financial results of per U.S. GAAP ASC 810. 4Front considers this measure to be an appropriate indicator of the growth and scope of the business.

Adjusted EBITDA is defined by the Company as earnings before interest, taxes, depreciation and amortization less share-based compensation expense and one-time charges related to acquisition, financing related costs and other non-recurring expenses. 4Front considers these measures to be an important indicator of the financial strength and performance of our business.

This news release was prepared by management of 4Front Ventures, which takes full responsibility for its contents. The Canadian Securities Exchange ("CSE") has not reviewed and does not accept responsibility for the adequacy of this news release. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States.

Systemwide Pro Forma Revenue Reconciliation

Revenue (GAAP)

$22,970

Less: Real Estate Income

2,890

Plus: Systemwide Revenue Adjustment

11,322

Systemwide Pro Forma Revenue (non-GAAP)

$31,402

4Front Announces Fourth Quarter and Fiscal Year 2020 Results and Provides Business Update

Tue, April 6, 2021

Q4 Systemwide Pro Forma Revenue increased to $25.0 million, with full year 2020 Systemwide Pro Forma sales of $88.1 million

Q4 Adjusted EBITDA increased 59% sequentially to $5.9 million, representing Adjusted EBITDA margin of 24%

Reiterated FY2021 guidance for Systemwide Pro Forma Revenue of $170-180 million and Adjusted EBITDA of $40-50 million

The Company's existing licensed projects at maturity represent a long-term revenue and EBITDA opportunity upwards of $650 million and $250 million, respectively

PHOENIX, April 6, 2021 /CNW/ - 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) ("4Front" or the "Company") today announced its financial results for the fourth quarter and fiscal year ended December 31, 2020. All financial information is presented in U.S. dollars unless otherwise indicated.

Fourth Quarter 2020 ("Q4 2020") Financial Results Highlights

Systemwide Pro Forma Revenue was $25.0 million

GAAP-reported revenue was $17.0 million

Adjusted EBITDA was $5.9 million

Fiscal Year 2020 ("FY 2020") Financial Results Highlights

Systemwide Pro Forma Revenue was $88.1 million

GAAP-reported revenue was $57.6 million, a 203% increase compared to the prior year

Adjusted EBITDA was $5.9 million

Operational Highlights

Opened second Illinois Mission Dispensary in Calumet City, and recently announced 2021 expansion plans in Illinois which includes the build out of an up to 558,000 square foot cultivation and production facility

Completed expansion and retrofit of cultivation and production facility in Georgetown, MA and Elk Grove Village, IL. Continued construction on state-of-the-art 185,000 square foot production facility in Commerce, California, fully funded and on track for Q2 2021 opening

Third Massachusetts dispensary in Brookline on track for Q2 2021 opening

Completed sale leaseback transaction with Innovative Industrial Properties; ended year with $18.9 million of cash and $47.3 million in long-term debt due in May 2024

Management Commentary

"4Front's strong fiscal 2020 performance is validation that our core strategy of replicating low-cost production methods, developed and refined within our Washington facilities, combined with our steadfast focus on execution is working," said Leo Gontmakher, Chief Executive Officer of 4Front. "We ended 2020 with tremendous business momentum that we have carried into the new year, as we scaled and replicated our operations across the growing adult-use markets of Massachusetts, Illinois and California."

Mr. Gontmakher added, "Our strong performance was driven by growing consumer demand for our quality manufactured products introduced in Massachusetts over the last year, the continued strength of the Illinois market, and a solid quarter out of our Washington facilities. We also completed the construction of our second Illinois dispensary in Calumet City, which opened in December, plus our cultivation/manufacturing facilities in Illinois and Massachusetts which we successfully transitioned into the 'Washington Way' with cultivation yields now meeting or exceeding those from our Washington facilities."

Mr. Gontmakher concluded, "We are well positioned to further scale the business and execute on our expansion strategy in 2021. This includes significantly expanding our cultivation and manufacturing footprint in Illinois and entering the $3 billion California market. Further bolstering our financial position is the fact that we are now generating positive operating cash flow, in line with our stated goals from the start of the year. Given the strength of our operations, I am pleased to reiterate our 2021 guidance of $170-$180 million in Pro Forma Systemwide Revenue and $40-$50 million in Adjusted EBITDA, with the longer-term view to generate $650 million in revenue and $250 million in EBITDA based on our current licensed footprint."

Business Updates and Developments

Q4 2020 Systemwide Pro Forma Revenue increased 12% quarter-over-quarter to $25.0 million. This growth was driven by continued robust activity across the Company's portfolio of operating assets, led by the first full quarter of recreational sales in Massachusetts and the opening of 4Front's second Illinois retail location in Calumet City.

Q4 Adjusted EBITDA increased 59% quarter-over-quarter to $5.9 million representing adjusted EBITDA margin of 24%. The Company continued to demonstrate considerable operating leverage in the fourth quarter, exceeding internal expectations, after initially achieving profitability during the third quarter of 2020. Through the combination of 4Front's low-cost production model, tight expense controls, and accelerating revenues the Company is well positioned to extend its profitability as it scales up its operating footprint. The Company achieved positive operating cash flow of $3.2 million in Q4 2020 and remains poised to show significant operating leverage in 2021.

In Q4 2020 4Front opened its second Illinois Mission Dispensary in Calumet City, and recently announced additional 2021 expansion plans in Illinois. The expansion plan includes the build out of an up to 558,000 square foot cultivation and production facility (the "Facility"), which the Company recently secured financing to build. Subsequent to the year end, the Company entered into definitive agreements with both the landowner and an affiliate of Innovative Industrial Properties, Inc., to acquire the land for $6.5 million and fund the approximately $45 million buildout of phase one of the Facility. The first phase constitutes 258,000 square feet of building comprising 65,000 square feet of flowering canopy with approximately 70,000 square feet of manufacturing space and is expected to be operational in the fourth quarter of 2022.

The Company's fully-funded, state-of-the-art 185,000 square foot manufacturing only facility in Commerce, California is nearing completion and is expected to be ready to serve the California cannabis market in Q2 2021. The Company is planning to launch its first full line of edibles, tinctures and vape products on California retail shelves starting in May 2021.

Construction remains on schedule at the Company's third Massachusetts dispensary in Brookline. Final inspection by the Cannabis Control Commission anticipated to occur in June 2021 and the Company remains confident that it will open the Brookline dispensary in Q2 2021.

2021 Outlook

Based on the continued strength of the Company's operations and robust consumer demand, 4Front reiterates its previously announced FY 2021 guidance and anticipates Systemwide Pro Forma Revenue of $170-180 million and Adjusted EBITDA of $40-50 million. This guidance is fully funded and contemplates only current operations plus the opening of the Brookline, Massachusetts dispensary and the Commerce production facility in Q2 of 2021. If such openings are delayed due to Covid-19, guidance could be negatively affected.

(Please see Note Regarding Non-GAAP Measures, Reconciliation, and Discussion below.) (*Please see the Financial Statement section below, and the Company's Fourth Quarter 2020 Condensed Consolidated Financial Statements and Management Discussion and Analysis ("MD&A"), available under the Company's EDGAR profile)

Additional Details

As of the date of the MD&A, there were the equivalent of 566,186,697 Class A Subordinate Voting Shares outstanding when calculated as if all share classes were converted to Subordinate Voting Shares. For further details regarding 4Front's share structure, please see its profile at www.thecse.com.

Conference Call

The Company will also host a conference call and webcast on Tuesday, April 6, 2021 at 5:00 p.m. ET to review its operational and financial results and provide an update on current business trends.

To join the call, dial 1-877-407-0792 toll free from the United States or Canada or 1-201-689-8263 if dialing from outside those countries. The webcast can be accessed at this link.

The call will be available for replay until Tuesday April 13, 2021. To access the telephone replay, dial 1-844-512-2921 toll free from the United States and Canada, or 1-412-317-6671 if dialing from outside those countries, and use this replay pin number: 13717894.

About 4Front Ventures Corp.

4Front (CSE: FFNT) (OTCQX: FFNTF) is a national multi-state cannabis operator and retailer, with a market advantage in mass-produced, low-cost quality branded cannabis products. 4Front manufactures and distributes a portfolio of over 25 cannabis brands including Marmas, Crystal Clear, Funky Monkey, Pebbles, and the Pure Ratios wellness collection, distributed through retail outlets and their chain of strategically positioned Mission branded dispensaries.

Headquartered in Phoenix, Arizona, 4Front has operations in Illinois, Massachusetts, California, Michigan, and Washington state. From plant genetics to the cannabis retail experience, 4Front's team applies expertise across the entire cannabis value chain. For more information, visit 4Front's website www.4frontventures.com.